Skip to main content
Clinical Trials/NCT05221177
NCT05221177
Completed
Not Applicable

Metabolic Cost of Suspension Exercise Training

University of Thessaly1 site in 1 country10 target enrollmentJanuary 3, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Body Composition
Sponsor
University of Thessaly
Enrollment
10
Locations
1
Primary Endpoint
Change in heart rate
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

In this study, the investigators will be able to estimate the metabolic cost of several foundational suspension training exercises.

Detailed Description

Suspension exercise training has become a popular cardiovascular training choice in fitness centers and athletic performance enhancement facilities. Despite widespread use and growing popularity, little is known about the metabolic demands of such a training method. Therefore, the purpose of this study was to quantify the cardiovascular and metabolic cost from various foundational suspension training exercises in order to contribute to a better planning of exercise programs in the real world. Ten healthy young adults were assigned to execute six suspension training exercises (acute bout) for 30 and 45 seconds. Anthropometric, metabolic, and performance measurements were conducted at baseline. The metabolic cost was estimated from heart rate, blood lactate, resting oxygen uptake, exercise oxygen uptake, and excess post-exercise oxygen consumption measurements using a portable gas analyzer.

Registry
clinicaltrials.gov
Start Date
January 3, 2022
End Date
March 13, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ioannis G. Fatouros

Professor

University of Thessaly

Eligibility Criteria

Inclusion Criteria

  • Aged between 18 and 35 years
  • Physically active individuals
  • Free of chronic diseases
  • Free of musculoskeletal injuries
  • Nonsmokers

Exclusion Criteria

  • Musculoskeletal injuries
  • Chronic diseases
  • Use of alcohol, caffeine and any type of ergogenic supplements or medication before (≤6 months) and throughout the study.

Outcomes

Primary Outcomes

Change in heart rate

Time Frame: At pre-exercise, during, and post-exercise session (single bout lasting 30 and 45 seconds)

Heart rate (bpm) will be measured with a wearable heart rate monitor

Change in blood lactate concentration (BLa)

Time Frame: At pre- and post-exercise session (single bout) at 3 minutes post-exercise

BLa (mmol/L) concentration will be measured in a microphotometer with commercially available kits.

Change in excess post-exercise oxygen consumption (EPOC)

Time Frame: At post-exercise session (single bout lasting 30 and 45 seconds)

EPOC (kcal) will be measured using a portable indirect calorimetry system

Change in exercise-induced energy expenditure

Time Frame: At pre-exercise, during, and post-exercise session (single bout lasting 30 and 45 seconds)

Exercise energy expenditure (kcal) will be measured using a portable indirect calorimetry system

Change in perceived exertion

Time Frame: At pre-exercise, during, and post-exercise session (single bout lasting 30 and 45 seconds)

Rating of perceived exertion (RPE) will be measured with the Borg scale (0-10)

Secondary Outcomes

  • Body height(At baseline)
  • Resting metabolic rate (RMR)(At baseline)
  • Body weight(At baseline)
  • Waist circumference (WC)(At baseline)
  • Maximal strength (1RM)(At baseline)
  • Body mass index (BMI)(At baseline)
  • Hip circumference (HC)(At baseline)
  • Body fat (BF)(At baseline)
  • Waist-to-hip ratio (WHR)(At baseline)
  • Muscular endurance(At baseline)
  • Fat mass (FM)(At baseline)
  • Fat-free mass (FFM)(At baseline)
  • Maximal oxygen consumption (VO2max)(At baseline)

Study Sites (1)

Loading locations...

Similar Trials